Skip to content
Open access · CC-BY via OpenAlex

AAV-mediated inducible expression of OSK and OSKM ameliorates acute ischemic and chronic steatotic liver disease

Cristina Maroto-Serrat, Rubén Rabadán-Ros, Enrique Montagud‐Marrahí, Marc Micó-Carnero, Carlos Rojano-Alfonso, Albert Caballeria-Casals, Francisco Sanus, Isabel Lopez-Sanchez, Jordi Gracia‐Sancho, Yosu Luque, Carmen Peralta, Josep Maria Campistol

Communications Biology · 2026

Abstract

Short-term expression of the Yamanaka factors Oct4, Sox2, Klf4 and c-Myc (OSKM) has been shown to promote liver regeneration, whereas sustained in vivo expression has been linked to tumorigenesis. Here, we evaluated doxycycline-inducible AAV-mediated expression of OSKM or OSK in male Wistar rats subjected to warm hepatic ischemia, metabolic dysfunction-associated steatohepatitis (MASH), or MASH with cirrhosis. A single AAV dose was administered, with transgene expression activated intermittently by doxycycline once a week. Short-term OSKM expression in healthy rats did not induce liver tumors up to 12 weeks after administration. In warm hepatic ischemia, both OSKM and OSK reduced liver damage. In contrast, only OSK improved chronic liver disease, attenuating tissue injury and fibrosis in MASH and MASH-cirrhosis and increasing survival. OSKM provided no therapeutic benefit in either chronic model and, in MASH without cirrhosis, exacerbated liver injury and fibrosis, induced tumors, and reduced survival. These findings support transient OSK expression as a potential therapeutic strategy for hepatic ischemia and MASH-associated liver damage.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1038/s42003-026-11116-9
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Maroto-Serrat, C., Rabadán-Ros, R., Montagud‐Marrahí, E., Micó-Carnero, M., Rojano-Alfonso, C., Caballeria-Casals, A., Sanus, F., Lopez-Sanchez, I., Gracia‐Sancho, J., Luque, Y., Peralta, C., &amp; Campistol, J.M. (2026). AAV-mediated inducible expression of OSK and OSKM ameliorates acute ischemic and chronic steatotic liver disease. <em>Communications Biology</em>. https://doi.org/10.1038/s42003-026-11116-9
Vancouver
Maroto-Serrat C, Rabadán-Ros R, Montagud‐Marrahí E, Micó-Carnero M, Rojano-Alfonso C, Caballeria-Casals A, et al. AAV-mediated inducible expression of OSK and OSKM ameliorates acute ischemic and chronic steatotic liver disease. Communications Biology. 2026. doi:10.1038/s42003-026-11116-9.
BibTeX
@article{cristina2026AAVmed, title = {AAV-mediated inducible expression of OSK and OSKM ameliorates acute ischemic and chronic steatotic liver disease}, author = {Cristina Maroto-Serrat and Rubén Rabadán-Ros and Enrique Montagud‐Marrahí and Marc Micó-Carnero and Carlos Rojano-Alfonso and Albert Caballeria-Casals and Francisco Sanus and Isabel Lopez-Sanchez and Jordi Gracia‐Sancho and Yosu Luque and Carmen Peralta and Josep Maria Campistol}, journal = {Communications Biology}, year = {2026}, doi = {10.1038/s42003-026-11116-9}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings